Generic Name and Formulations:
Nitroglycerin 2% (15mg/inch); oint; contains lanolin.
Indications for NITRO-BID:
Prophylaxis of angina. Not for acute attacks.
Apply, using applicator, usually to the chest and occlude. Initially ½ inch on awakening and then 6 hrs later; may increase to 1 inch, then to 2 inches twice daily.
Acute MI. CHF. Hypotension. Volume depleted. Hypertrophic cardiomyopathy. Avoid abrupt cessation. Elderly. Pregnancy (Cat.C). Nursing mothers.
See Contraindications. Severe hypotension with sildenafil. Vasodilating effects potentiated with alcohol, other vasodilators. Orthostatic hypotension with calcium channel blockers.
Headache, dizziness, flushing, orthostatic hypotension, rash; syncope, methemoglobinemia (rare).
Oint—30g, 60g (w. applicator); Oint—48 x 1g packets
Endocrinology Advisor Articles
- Cushing Syndrome Results in Poor Quality of Life Even After Remission
- DPP-4 Inhibitors and Incidence of Rheumatoid Arthritis in Type 2 Diabetes
- Cost-Benefit Analysis of Insulin Analogs in Type 2 Diabetes
- Nonfunctioning Adrenal Incidentaloma Associated With Metabolic Syndrome
- Low Predictive Power of Biomarkers for Estimated Glomerular Filtration Rate Decline
- Nutraceuticals May Benefit Patients Who Are Statin Intolerant
- Link Between Gestational Diabetes and Risk for CVD and Diabetes in Hispanic/Latina Population
- Clinical Characteristics Altering Risks and Benefits of Sulfonylureas and Thiazolidinedione Therapy in T2D
- 6 Factors Related to Inclusion in Health Care Workplace Identified
- Weight Gain After Quitting Smoking May Increase Risk for T2D